Hermes Biosciences

Based in the US, Hermes Biosciences engages in the development of innovative technology for isolating extracellular vesicles, focusing on exosome purification from biological fluids and cell culture media to enhance research and clinical applications. Hermes Biosciences is dedicated to advancing the field of exosome research through the development of its specialized benchtop isolation system. The company was founded to address the growing demand for efficient exosome purification methods. Its headquarters are located in the United States and it has conducted two investment deals since inception.

The company has raised pre-seed funding from General Inception, marking a significant step in its growth trajectory. Hermes Biosciences specializes in the development of a benchtop, hands-off extracellular vesicle isolation system designed to purify exosomes from various biological fluids and cell culture media. This technology enables researchers to process samples quickly and efficiently, facilitating deeper understanding of exosome functions and their applications in clinical fields such as oncology, degenerative diseases, and regenerative medicine. The company primarily serves academic institutions, research laboratories, and clinical research organizations across North America, Europe, and Asia.

The revenue model of Hermes Biosciences is structured around direct sales of its exosome isolation systems to research institutions and clinical laboratories through procurement agreements. Clients purchase the equipment alongside related consumables and support services. The primary product has established a foothold in the market, appealing to both B2B transactions and research collaborations. Pricing plans cater to various client needs, including bulk purchases or service agreements for maintenance and support.

Hermes Biosciences plans to expand its product offerings with new exosome isolation systems and aims to penetrate additional markets in Europe and Asia by 2025. The recent pre-seed funding from General Inception will be utilized to support these initiatives, enhancing product development and market expansion efforts.